67.有關抗腫瘤藥品心臟毒性之敘述,下列何者錯誤?
(A)接受doxorubicin治療者,應注意心臟功能,且應注意累積劑量
(B)mitoxantrone化學結構與doxorubicin類似,也應該注意心臟毒性
(C)nilotinib、dasatinib、lapatinib、sunitinib都可能造成QTc prolongation,應注意藥品交互作用
(D)fluorouracil以IV bolus給藥時,所造成心絞痛的發生率遠超過以多日continuous infusion給藥
答案:登入後查看
統計: A(20), B(1396), C(835), D(3500), E(0) #2180271
統計: A(20), B(1396), C(835), D(3500), E(0) #2180271
詳解 (共 10 筆)
#4173413
選項D
Based on postmarketing reports, fluorouracil may cause cardiotoxicity (angina, MI/ischemia, arrhythmia, and heart failure). Risk factors for cardiotoxicity include continuous infusion administration (versus IV bolus) and coronary artery disease. [Uptodate]
32
0
#4750361
Fluorouracil毒性比較
Continuous infusion: Cardiotoxicity (angina, MI/ischemia, arrhythmia, and heart failure)., Hand-foot syndrome
Bolus: GI toxicity, 血液毒性?
13
0